Evidence map›Paper›PMID 28398700›Full record

ArticleGenes, chromosomes & cancer2017

Differential requirements for DNA repair proteins in immortalized cell lines using alternative lengthening of telomere mechanisms.

Alaina R Martinez, Zeenia Kaul, Jeffrey D Parvin, Joanna Groden

Open access · greenAbstract read
In one paragraph

Article in Genes, chromosomes & cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Coordinated roles of SLX4 and MutSβ in DNA repair and the maintenance of genome stability.Critical reviews in biochemistry and molecular biology · 2021
    Review
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Alaina R MartinezDepartment of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, Ohio.ORCID 0000-0002-6652-1373
Zeenia KaulDepartment of Cancer Biology and Genetics, The Ohio State University College of Medicine, Columbus, Ohio.
Jeffrey D ParvinDepartment of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, Ohio.
Joanna GrodenDepartment of Cancer Biology and Genetics, The Ohio State University College of Medicine, Columbus, Ohio.
Cancer Genetics (United States) · USThe Ohio State University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
The Ohio State University Center for Clinical and Translational Science (UL1)UL1TR000090 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2012 to 2013
$7.9M
Postdoctoral Training in Cancer GeneticsT32CA106196 · NCI · OHIO STATE UNIVERSITY · PI DE LA CHAPELLE, ALBERT · 2004 to 2013
$3.6M
Functions of the BLM Helicase in Telomere MaintenanceR01CA117898 · NCI · OHIO STATE UNIVERSITY · PI GRODEN, JOANNA LOUISE · 2008 to 2012
$1.5M
The Ohio State University Center for Clinical and Translational Science (KL2)KL2TR000112 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2012 to 2013
$855k
The Ohio State University Center for Clinical and Translational Science (TL1)TL1TR000091 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2012 to 2013
$384k
BRCA1 interacting proteins important for DNA repairR21CA198228 · NCI · OHIO STATE UNIVERSITY · PI FREITAS, MICHAEL A., PARVIN, JEFFREY D · 2016 to 2017
$351k
NCATS NIH HHS KL2 TR000112NCATS NIH HHS TL1 TR000091NCATS NIH HHS UL1 TR000090NCI NIH HHS P30 CA016058NCI NIH HHS R01 CA117898NCI NIH HHS R21 CA198228NCI NIH HHS T32 CA106196
6 · The paper itself

Abstract

Cancer cells require telomere maintenance to enable uncontrolled growth. Most often telomerase is activated, although a subset of human cancers are telomerase-negative and depend on recombination-based mechanisms known as ALT (Alternative Lengthening of Telomeres). ALT depends on proteins that are essential for homologous recombination, including BLM and the MRN complex, to extend telomeres. This study surveyed the requirement for requisite homologous recombination proteins, yet to be studied in human ALT cell lines, by protein depletion using RNA interference. Effects on ALT were evaluated by measuring C-circle abundance, a marker of ALT. Surprisingly, several proteins essential for homologous recombination, BARD1, BRCA2, and WRN, were dispensable for C-circle production, while PALB2 had varying effects on C-circles among ALT cell lines. Depletion of homologous recombination proteins BRCA1 and BLM, which have been previously studied in ALT, decreased C-circles in all ALT cell lines. Depletion of the non-homologous end joining proteins 53BP1 and LIG4 had no effect on C-circles in any ALT cell line. Proteins such as chromatin modifiers that recruit double-strand break proteins, RNF8 and RNF168, and other proteins loosely grouped into excision DNA repair processes, XPA, MSH2, and MPG, reduced C-circles in some ALT cell lines. MSH2 depletion also reduced recombination at telomeres as measured by intertelomeric exchanges. Collectively, the requirement for DNA repair proteins varied between the ALT cell lines compared. In sum, our study suggests that ALT proceeds by multiple mechanisms that differ between cell lines and that some of these depend on DNA repair proteins not associated with homologous recombination pathways.

Indexed as

Telomere HomeostasisDNA RepairDNA Repair EnzymesHeLa CellsHumansNeoplasmsDNA Repair Enzymes

Identifiers

PMID28398700
PMCPMC7170175
OpenAlexW2607494366

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.